scholarly article | Q13442814 |
P50 | author | Karen J Cruickshanks | Q114312892 |
Michael Y. Tsai | Q37369579 | ||
P2093 | author name string | Barbara E K Klein | |
Ronald Klein | |||
Cynthia M Carlsson | |||
Rick Chappell | |||
Mary E Fischer | |||
Carla R Schubert | |||
Margarete A Wichmann | |||
P2860 | cites work | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 |
Inflammation, stress, and diabetes | Q24523336 | ||
Inflammation and cancer | Q24649640 | ||
Vascular risk factors and dementia: how to move forward? | Q24650263 | ||
“Mini-mental state” | Q25938989 | ||
The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
Inflammation and Alzheimer's disease | Q28138617 | ||
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
Carotid atherosclerosis and 10-year changes in cognitive function | Q30448557 | ||
Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults | Q30475279 | ||
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group | Q67748287 | ||
Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging | Q75220942 | ||
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators | Q78017116 | ||
Normative Data Stratified by Age and Education for Two Measures of Verbal Fluency: FAS and Animal Naming | Q33194396 | ||
Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals | Q33513475 | ||
Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty | Q33896033 | ||
Inflammation: the link between insulin resistance, obesity and diabetes | Q34286695 | ||
Demonstrating the case that AD is a vascular disease: epidemiologic evidence | Q34662343 | ||
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm | Q35020920 | ||
Proinflammatory cytokines, sickness behavior, and Alzheimer disease | Q35104455 | ||
Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer's disease and dementia | Q35610567 | ||
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study | Q35678048 | ||
A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. | Q36008935 | ||
Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars | Q36215688 | ||
Inflammation markers predicting frailty and mortality in the elderly. | Q36388062 | ||
Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study | Q36439930 | ||
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging | Q36475250 | ||
The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis | Q36957501 | ||
Long-term variability of inflammatory markers and associated factors in a population-based cohort | Q37096276 | ||
Evidence for a cytokine model of cognitive function | Q37321439 | ||
The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 | ||
Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study | Q39478857 | ||
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study | Q40208679 | ||
The Beaver Dam Eye Study: visual acuity | Q44375765 | ||
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study | Q44493428 | ||
Postmenopausal hormone therapy and its association with cognitive impairment | Q44650297 | ||
Association of statins with inflammatory cytokines: a population-based Colaus study | Q44950438 | ||
Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging | Q45205011 | ||
Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004. | Q46142285 | ||
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study | Q47433416 | ||
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study | Q47591273 | ||
Cytokines and sickness behavior. | Q47966462 | ||
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. | Q48576539 | ||
Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. | Q53250180 | ||
Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. | Q53302617 | ||
Inflammation biomarkers and near-term death in older men. | Q53581064 | ||
High CRP with "normal" cognition: a resilient phenotype in old age. | Q54074727 | ||
Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests | Q57529701 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic inflammation | Q7663815 |
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 1683-1691 | |
P577 | publication date | 2014-08-14 | |
P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
P1476 | title | Long-term systemic inflammation and cognitive impairment in a population-based cohort | |
P478 | volume | 62 |
Q38808547 | A Systematic Review and Meta-Analysis of the Association between Helicobacterpylori Infection and Dementia |
Q90077592 | Aging-related changes in fluid intelligence, muscle and adipose mass, and sex-specific immunologic mediation: A longitudinal UK Biobank study |
Q64460706 | An Epidemiologic Study of the Association between Free Recall Dichotic Digits Test Performance and Vascular Health |
Q50026626 | Association of 10-year C-reactive protein trajectories with markers of healthy aging: findings from the English Longitudinal Study of Ageing |
Q90638295 | Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson's Disease Severity |
Q47560225 | Development and psychometric properties of the Healthy Aging Activity Engagement Scale (HAAE). |
Q38833716 | Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective |
Q36635024 | Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST). |
Q37219271 | Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians. |
Q40704505 | Host factors associated with serologic inflammatory markers assessed using multiplex assays |
Q50437508 | Independent and Differential Effects of Obesity and Hypertension on Cognitive and Functional Abilities |
Q47336378 | Inflammation and Cognition in Older Adults: Evidence from Taiwan. |
Q47968289 | Influence of Flaxseed Lignan Supplementation to Older Adults on Biochemical and Functional Outcome Measures of Inflammation. |
Q36348370 | NSAID Use and Incident Cognitive Impairment in a Population-based Cohort |
Q47867114 | Polymorphisms in cytokine genes influence cognitive and functional performance in a population aged 75 years and above. |
Q39007036 | Prior infection exacerbates postoperative cognitive dysfunction in aged rats. |
Q47213450 | Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients |
Q36349870 | Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men. |
Q35681879 | The Effects of Stress on Cognitive Aging, Physiology and Emotion (ESCAPE) Project |
Q36578522 | The HIV-1 transgenic rat model of neuroHIV. |
Q33607272 | The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment. |
Q47550084 | The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway |
Q35678169 | The beneficial role of anti-inflammatory dietary ingredients in attenuating markers of chronic low-grade inflammation in aging |
Q26750987 | The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ |
Q47660161 | The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old. |
Q64986942 | Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study. |
Q38392892 | Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women |
Search more.